DPP4 and type 2 diabetes mellitus: Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) are classified as a new oral anti-diabetic medication and are widely used for management of type 2 diabetes mellitus (Baetta and Corsini, 2011).